Results 231 to 240 of about 31,151 (261)

Chikungunya Virus–Like Particle Vaccine

JAMA, 2020
Nishant, Jaiswal, Shreya, Singh, Meenu, Singh   +2 more
openaire   +2 more sources

Bacteriophage Virus-Like Particles: Platforms for Vaccine Design

2023
Virus-like particles (VLPs) derived from bacteriophages have many applications in biomedical sciences, especially in the development of candidate vaccines against viral and bacterial infections. Bacteriophage VLPs can be manufactured cheaply and in large quantities in bacteria compared to eukaryotic expression systems.
openaire   +2 more sources

Chimeric Virus-Like Particles as Vaccines

Biological Chemistry, 1999
D H, Krüger, R, Ulrich, W H, Gerlich
openaire   +2 more sources

Virus-like particle vaccines

2022
Ekta Mukhopadhyay, Adrian V.S. Hill, Ahmed M. Salman   +2 more
openaire   +1 more source

PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2

Heliyon, 2021
Dilip Kumar, Abhishek Mukherjee, Sourav Singha Roy   +2 more
exaly  

Current development of Zika virus vaccines with special emphasis on virus-like particle technology

Expert Review of Vaccines, 2021
Velasco Cimica, JOSÉ M Galarza, Timothy T Stedman   +2 more
exaly  

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Lancet, The, 2006
Diane M Harper, Eduardo L Franco, Cosette M Wheeler   +2 more
exaly  

Virus-like particle-based vaccines against hepatitis C virus infection

Expert Review of Vaccines, 2013
Bertrand Bellier, David Klatzmann
exaly  

Chikungunya Virus–Like Particle Vaccine—Reply

JAMA, 2020
openaire   +2 more sources

Virus-like particle display of HER2 induces potent anti-cancer responses

OncoImmunology, 2018
Arianna Palladini, Susan Thrane, Christoph M Janitzek   +2 more
exaly